A new cardiac biomarker, the “Cardiac myosin-binding protein C” (cMyC), had been recently introduced, which constitutes an abundant sarcomeric protein with a unique cardiac isoform that is released upon cardiac damage or iatrogenic MI much faster than the troponins [4, 26]. Here, MYBPC3 is linked to myocardial infarction.